Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis.
about
Prognostic Value and Clinicopathological Significance of p-stat3 Among Gastric Carcinoma Patients: A Systematic Review and Meta-AnalysisPersonalized medicine in gastric cancer: Where are we and where are we going?Advanced gastric cancer: What we know and what we still have to learnState of the art management of metastatic gastroesophageal cancerHER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the StomachHER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologistsFrom molecular classification to targeted therapeutics: the changing face of systemic therapy in metastatic gastroesophageal cancerExome analysis reveals differentially mutated gene signatures of stage, grade and subtype in breast cancers.Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patientsActivation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage.Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer patients after surgery with curative intent.Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer.HER2 expression in gastric and oesophageal cancer: a meta-analytic reviewHER2 in solid tumors: more than 10 years under the microscope; where are we now?Plasma membrane proteomic analysis of human Gastric Cancer tissues: revealing flotillin 1 as a marker for Gastric Cancer.Clinicopathologic and molecular features associated with patient age in gastric cancerExpression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.Expression of APPL1 is correlated with clinicopathologic characteristics and poor prognosis in patients with gastric cancer.Associations between serum CA724 and HER2 overexpression among stage II-III resectable gastric cancer patients: an observational study.State of the art in anti-cancer mAbs.Targeted therapy in gastric cancer.Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biological markers.An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis.Distinct prognostic values of YAP1 in gastric cancer.Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysisThe relative efficacy and safety of targeted agents used in combination with chemotherapy in treating patients with untreated advanced gastric cancer: a network meta-analysis.Prognostic significance of HER2 expression based on trastuzumab for gastric cancer (ToGA) criteria in gastric cancer: an updated meta-analysis.HER2 testing in malignant effusions of metastatic gastric carcinoma: is it feasible?The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer.Optimal management of resected gastric cancer.
P2860
Q26769034-36BD8DBD-69FB-4D45-BF19-AE08A6BCE9A4Q26774521-B72BB588-65A6-4B72-872F-A65A80BD3E3DQ26774528-4CBCE031-CB01-49E0-934E-8E1B219D62C2Q26779217-8BD0BBFF-C480-4A44-800C-D45CF530690BQ26780318-1D5B6C86-1D27-47A2-A3C7-650EBFC400BDQ28078111-018B0A46-5864-4F50-8205-99B343A07BF2Q28082921-7E235CDA-58AD-4512-A40C-67242D1BC629Q30372977-E75E8119-6CD2-434F-B5A0-7733FE0E1B53Q31112933-F7AC1909-FECE-4069-AEA2-F562C40690A3Q33670896-29C19BE0-2259-486E-B4EB-723B8256AD56Q34308255-2E5C53E3-236A-43A7-96DB-9ADFA3029BE9Q34954681-3E8D4E76-1EEE-4787-A104-D105DFD48017Q35029025-CFF3FCCA-896A-4A43-A64A-3C6377594B9BQ35211263-11FC1CE1-2BDC-4AD1-849D-5BCB76DC7C14Q35623711-94AD833E-F8A1-41B6-928D-B25263E21FFDQ35716215-FA741387-DBC8-42D1-82AA-9D52191C1FA7Q36547753-917DB038-2D42-47CA-A1B6-252A4A83DA31Q36807851-F92CE84E-66DB-4C5E-AD17-19135579543BQ37269090-74EC63EA-DB11-4BAE-AA92-AD4D8A8F8464Q37655585-5FC1A16A-6EFC-4112-B5AB-FEC646013096Q38364292-748C77BF-2EC9-4BA4-8BF8-4680549D2F7FQ38687568-533C9B9B-FC20-4820-A5E6-1E574F0E96A7Q38691748-179FB254-98D0-4393-9051-247C0F19CC8DQ40256327-393D38C4-B2AD-4486-B1D8-1825BC221594Q40332121-9F9F2668-D003-4EB7-8BCE-96046DDB7A7BQ42265610-8423E7AB-A599-4547-BB97-F6A1245B0BC1Q43479667-DF9D139C-291A-4622-8349-027359167A19Q54312070-FB4F0293-9629-4F88-93B8-5ACFC549E590Q55069791-975B0C42-3026-48A7-9351-EDCBBC1E30D2Q55359616-40A295B3-7FDB-40F9-9FB3-5DDB548D2AB8
P2860
Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Prognostic role of human epide ...... atic review and meta-analysis.
@en
type
label
Prognostic role of human epide ...... atic review and meta-analysis.
@en
prefLabel
Prognostic role of human epide ...... atic review and meta-analysis.
@en
P2093
P1476
Prognostic role of human epide ...... atic review and meta-analysis.
@en
P2093
Cheng Chen
Jing-mo Yang
Shi-lian Hu
Ting-juan Xu
Ting-ting Hu
Wei-ping Xu
P304
P356
10.1016/J.ARCMED.2013.07.001
P577
2013-07-16T00:00:00Z